William Blair Has Bearish Estimate for USPH Q1 Earnings

U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) - Equities research analysts at William Blair cut their Q1 2025 EPS estimates for shares of U.S. Physical Therapy in a report released on Thursday, February 27th. William Blair analyst J. Haase now forecasts that the company will post earnings of $0.56 per share for the quarter, down from their previous estimate of $0.59. William Blair currently has a "Market Perform" rating on the stock. The consensus estimate for U.S. Physical Therapy's current full-year earnings is $2.67 per share. William Blair also issued estimates for U.S. Physical Therapy's Q1 2025 earnings at $0.56 EPS, Q2 2025 earnings at $0.79 EPS, Q2 2025 earnings at $0.79 EPS, Q4 2025 earnings at $0.78 EPS, Q4 2025 earnings at $0.78 EPS, FY2025 earnings at $2.96 EPS and FY2025 earnings at $2.96 EPS.

Several other brokerages have also commented on USPH. StockNews.com lowered shares of U.S. Physical Therapy from a "hold" rating to a "sell" rating in a report on Friday. Bank of America upgraded U.S. Physical Therapy from a "neutral" rating to a "buy" rating and raised their price target for the stock from $100.00 to $115.00 in a research report on Monday, December 16th. JMP Securities started coverage on U.S. Physical Therapy in a report on Monday, December 16th. They issued an "outperform" rating and a $113.00 price objective on the stock. Barrington Research lowered their target price on U.S. Physical Therapy from $108.00 to $98.00 and set an "outperform" rating for the company in a report on Friday. Finally, Citizens Jmp raised shares of U.S. Physical Therapy to a "strong-buy" rating in a research note on Monday, December 16th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $111.50.

Remove Ads

U.S. Physical Therapy Trading Down 0.2 %

NYSE USPH traded down $0.18 during trading hours on Friday, reaching $79.46. The company had a trading volume of 68,752 shares, compared to its average volume of 100,250. U.S. Physical Therapy has a 1-year low of $76.18 and a 1-year high of $113.63. The stock has a market capitalization of $1.20 billion, a P/E ratio of 84.82, a price-to-earnings-growth ratio of 3.54 and a beta of 1.48. The stock has a 50-day moving average of $87.99 and a 200 day moving average of $87.62. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.27.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last announced its quarterly earnings results on Wednesday, February 26th. The company reported $0.65 EPS for the quarter, missing the consensus estimate of $0.69 by ($0.04). The business had revenue of $180.45 million during the quarter, compared to analyst estimates of $173.10 million. U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%.

Hedge Funds Weigh In On U.S. Physical Therapy

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Point72 Asset Management L.P. purchased a new stake in U.S. Physical Therapy in the 4th quarter valued at approximately $18,886,000. Bahl & Gaynor Inc. raised its position in U.S. Physical Therapy by 135.4% in the fourth quarter. Bahl & Gaynor Inc. now owns 260,125 shares of the company's stock worth $23,076,000 after acquiring an additional 149,622 shares in the last quarter. State Street Corp lifted its holdings in U.S. Physical Therapy by 17.5% in the third quarter. State Street Corp now owns 667,868 shares of the company's stock valued at $56,522,000 after acquiring an additional 99,244 shares during the period. Copeland Capital Management LLC boosted its position in shares of U.S. Physical Therapy by 9.5% during the 4th quarter. Copeland Capital Management LLC now owns 839,356 shares of the company's stock worth $74,459,000 after purchasing an additional 72,715 shares in the last quarter. Finally, Raymond James Financial Inc. acquired a new position in shares of U.S. Physical Therapy during the 4th quarter worth $6,240,000.

Insider Activity at U.S. Physical Therapy

In other news, CFO Carey P. Hendrickson sold 516 shares of the firm's stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $96.25, for a total transaction of $49,665.00. Following the transaction, the chief financial officer now directly owns 20,469 shares in the company, valued at approximately $1,970,141.25. This trade represents a 2.46 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. 1.70% of the stock is currently owned by corporate insiders.

U.S. Physical Therapy Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Investors of record on Friday, March 14th will be paid a $0.45 dividend. The ex-dividend date is Friday, March 14th. This represents a $1.80 dividend on an annualized basis and a yield of 2.27%. This is an increase from U.S. Physical Therapy's previous quarterly dividend of $0.44. U.S. Physical Therapy's payout ratio is currently 97.83%.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.